The Bayer AG annual shareholders’ meeting got underway Tuesday in Germany, drawing the attention of not only investors and analysts but also activists, lawyers and cancer patients who want to see Bayer make amends for alleged misdeeds by Monsanto, which Bayer bought two years ago. The meeting was to be an in-person event in Bonn, … Bayer shareholder meeting draws protests, pleas from cancer patients